Julie Rogers
Family · Shavano Park, TXNPI 1083002851
Payments from drug & device makers
Across 860 payments — averaging $26.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$3K
- Lilly USA, LLC$2K
- Dexcom, Inc.$2K
- Cequr Corporation$1K
- AstraZeneca$1K
- Amgen$970
- plus $13K from 50 others
What the payments were for
- Food & beverage$23,05799%
- Education$250%
- Gifts$1191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iLet Bionic Pancreas$1,573
- CeQur Simplicity$1,299
- Korlym$612
- iLet Insulin Infusion Kit Inset$524
- iLet Insulin Infusion Kit Contact Detach$524
- DEXCOM G6 TRANSMITTER$499
- FARXIGA$467
- TWIIST$413
- MOUNJARO$376
- Sogroya$371
- DEXCOM G7 GSS (161)$275
- Wegovy$250
- Qutenza$250
- ZEPBOUND$240
- MINIMED 780G$151
- DEXCOM STELO GLUCOSE BIOSENSOR$150
- EVERSENSE E3 SENSOR KIT - RETAIL$141
- FREESTYLE LIBRE 3$139
- TEPEZZA$132
- Omnipod$130
How this compares
$23,201 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 167 | $223,376 |
| MounjaroTirzepatide | 122 | $164,157 |
| JardianceEmpagliflozin | 87 | $127,214 |
| TrulicityDulaglutide | 44 | $62,399 |
| FarxigaDapagliflozin Propanediol | 61 | $62,211 |
| TymlosAbaloparatide | 13 | $42,988 |
| Xigduo XrDapaglifloz Propaned/Metformin | 27 | $35,684 |
| Tresiba Flextouch U-100Insulin Degludec | 27 | $23,131 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 20 | $19,906 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 11 | $17,677 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $17,152 |
| KerendiaFinerenone | 11 | $15,925 |
| SynthroidLevothyroxine Sodium | 158 | $15,458 |
| JanuviaSitagliptin Phosphate | 26 | $14,679 |
| Repatha SureclickEvolocumab | 12 | $8,705 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $3,168 | $228,056180 claims |
| Lilly USA, LLCMounjaro, Trulicity | $2,062 | $226,556166 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $605 | $147,120107 claims |
| AstraZenecaFarxiga | $1,195 | $62,21161 claims |
| Radius Health, Inc.Tymlos | $679 | $42,98813 claims |
| BayerKerendia | $159 | $15,92511 claims |
| AbbVieSynthroid | $316 | $15,458158 claims |
| MerckJanuvia | $61 | $14,67926 claims |
| Antares Pharma, Inc.Xyosted | $332 | $7,77914 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid | $162 | $2,168130 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 15,456 family providers in Texas.
Other family in Shavano Park
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.